UK markets closed
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • FTSE 250

    20,338.96
    +93.53 (+0.46%)
     
  • AIM

    933.20
    +4.84 (+0.52%)
     
  • GBP/EUR

    1.1820
    +0.0002 (+0.02%)
     
  • GBP/USD

    1.2139
    -0.0064 (-0.52%)
     
  • BTC-GBP

    20,101.68
    +72.26 (+0.36%)
     
  • CMC Crypto 200

    574.64
    +3.36 (+0.59%)
     
  • S&P 500

    4,280.15
    +72.88 (+1.73%)
     
  • DOW

    33,761.05
    +424.38 (+1.27%)
     
  • CRUDE OIL

    91.88
    -2.46 (-2.61%)
     
  • GOLD FUTURES

    1,818.90
    +11.70 (+0.65%)
     
  • NIKKEI 225

    28,546.98
    +727.65 (+2.62%)
     
  • HANG SENG

    20,175.62
    +93.19 (+0.46%)
     
  • DAX

    13,795.85
    +101.34 (+0.74%)
     
  • CAC 40

    6,553.86
    +9.19 (+0.14%)
     

At an estimated value of over USD 86.51 billion in 2021, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a CAGR of 3.3% and valued at over USD 118.57 billion over the forecast year 2022-2030.

·4-min read
ReportLinker
ReportLinker

In Vitro Diagnostics (IVD) Market by Product & Service (Instruments, Reagents, and Software & Services), Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Clinical Chemistry, Tissue Diagnostics, and Others), Application (Infectious Diseases, Cancer, Immune System Disorders, Cardiac Diseases, Nephrological Diseases, Gastrointestinal Diseases, and Others), and End User (Standalone Laboratory, Academic & Medical Schools, Hospitals, Point of Care, and Others): Global Opportunity Analysis and Industry Forecast, 2022 – 2030

New York, July 19, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "In Vitro Diagnostics Market by Product & Service, Technique, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2022 – 2030" - https://www.reportlinker.com/p06293608/?utm_source=GNW

Market Definition:

At an estimated value of over USD 86.51 billion in 2021, the Global In Vitro Diagnostics (IVD) Market is predicted to thrive at a CAGR of 3.3% and valued at over USD 118.57 billion over the forecast year 2022-2030. In vitro diagnostics (IVD) are the tests for detecting disease and infections. It is done on samples such as tissue or blood taken from the human body. There are several types of in vitro diagnostic instruments that offers features such as tissue diagnostics, hematology, immunodiagnostics, and molecular diagnostics. The in vitro diagnostics is experiencing a significant popularity in healthcare sector due to its efficacy in diagnosing numerous medical conditions such as infectious diseases, cardiac disorders, cancer, and nephrological disorders.

Market Dynamics and Trends

Upsurge in number of in vitro diagnostic tests across the globe owing to the increased incidences of infectious and chronic diseases drives the growth of IVD market. In addition, rise in geriatric population, which is vulnerable to immunological disorders have been pushing the growth of the market globally. However, strict government regulations related to the in-vitro diagnostics along with unfavorable compensation policies hamper the growth of the market. On the other hand, high growth shown by the developing countries in terms of population & proliferation of in vitro diagnostic tests is expected to create lucrative opportunities to further propel market growth throughout the forecast period.

Market Segmentations and Scope of the Study:

The global In vitro diagnostics (IVD) market share is segmented on the basis of product & service, technique, application, end user, and geography. On the basis of product & service, the market is categorized into Instruments, Reagents, and Software & Services. According to the technique, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, clinical chemistry, tissue diagnostics, and others. As per the application, the market is divided into infectious diseases, cancer, immune system disorders, cardiac diseases, nephrological diseases, gastrointestinal diseases, and others. On the basis of end user, the market is segmented into standalone laboratory, academic & medical schools, hospitals, point of care, and others. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia Pacific and RoW.

Geographical Analysis

In terms of geography, North America held major share of the market in 2019. This is attributed to the well-established healthcare system and the healthcare related awareness among people across the region. However, Asia-pacific is expected to witness highest growth rate during the forecast period, due to the surge in healthcare expenditure and rise in prevalence of diabetes in the region. Moreover, massively growing patient base of chronic diseases in the region that require IVD testing is projected to be opportunistic for the market growth.

Competitive Landscape

Lucrative growth opportunities make the In Vitro Diagnostics (IVD) market highly competitive. Some of the major players in the market are Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, BioMérieux SA, Sysmex Corporation, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche AG, Siemens AG, QIAGEN N.V., Thermo Fisher Scientific, Inc. and many more. A number of developmental strategies have been adopted by companies in the past few years. For instance, in October 2020, Quanterix Corporation entered into a non-exclusive royalty-bearing license agreement with Abbott Laboratories. This agreement grants Abbott an access to Quanterix’ portfolio of bead-based technology patents for the use in in vitro diagnostic (IVD) applications.

KEY MARKET SEGMENTS:

• Global In Vitro Diagnostics (IVD) Market– By Product & Service
o Instruments
o Reagents
o Software & Services
• Global In Vitro Diagnostics (IVD) Market – By Technique
o Immunodiagnostics
o Enzyme-linked immunosorbent assay (ELISA)
o Rapid Tests
o Enzyme-linked immunospot (ELISPOT)
o Radioimmunoassay (RIA)
o Western blot
o Hematology
o Molecular Diagnostics
o Polymerize chain reaction (PCR)
o Isothermal Nucleic acid amplification technology (INAAT)
o Hybridization
o DNA diagnostics
o Microarray
o Others
o Clinical Chemistry
o Basic metabolic panel
o Liver panel
o Renal profile
o Lipid profile
o Thyroid function panel
o Electrolyte panel
o Specialty chemicals
o Tissue Diagnostics
o Others
• Global In Vitro Diagnostics (IVD) Market – By Application
o Infectious Diseases
o Cancer
o Immune System Disorders
o Cardiac Diseases
o Nephrological Diseases
o Gastrointestinal Diseases
o Others
• Global In Vitro Diagnostics (IVD) Market – By End User
o Standalone Laboratory
o Academic & Medical Schools
o Hospitals
o Point of Care
o Others
• Global In Vitro Diagnostics (IVD) Market – By Geography
o North America
U.S.
Canada
Mexico
o Europe
UK
Germany
France
Italy
Spain
Rest of Europe
o Asia-Pacific
China
India
Japan
Australia
South Korea
Rest of Asia-Pacific
o RoW
Latin America
Middle East
Africa
Read the full report: https://www.reportlinker.com/p06293608/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting